Kedudukan dalam Saham
#15850
Founded in Seoul, South Korea, in 2010, AbClon Inc. is a biopharmaceutical... Founded in Seoul, South Korea, in 2010, AbClon Inc. is a biopharmaceutical company engaged in the discovery and development of antibody-based drugs, with operations spanning South Korea and Sweden. The firm's developmental pipeline encompasses therapies derived from distinct technological platforms: the NEST platform addresses breast and gastric cancers; the AffiMab platform targets colon cancer and various autoimmune conditions; and the CAR-T platform is engineered for hematologic and ovarian cancers.
Perubahan (1 hari)
-3.46%
Perubahan (1 tahun)
129.62%
Perdagangan AbClon Inc. (174900)
Harga 174900 dengan permodalan pasaran b
Modal pasaran bagi AbClon Inc.(174900)
Modal Pasaran: $327.24M
Sehingga September 2026, AbClon Inc. mempunyai modal pasaran sebanyak $327.24M. Ini menjadikan AbClon Inc. syarikat ke-15850th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran AbClon Inc. dari 2017 hingga 2026
174900 berbanding dengan 5 teratas yang paling popular stocks
| Harga 174900 |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.310T
|
+1,622,572.33%
|
|
|
|
|
$4.783T
|
+1,461,449.35%
|
|
|
|
|
$4.028T
|
+1,230,916.60%
|
|
|
|
|
$3.718T
|
+1,136,119.80%
|
|
|
|
|
$2.736T
|
+835,998.02%
|
